BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37846943)

  • 1. What can inherited immunodeficiencies reveal about pyoderma gangrenosum?
    Oprea Y; Kody S; Shakshouk H; Greiling TM; Anstey KM; Ortega-Loayza AG
    Exp Dermatol; 2024 Jan; 33(1):e14954. PubMed ID: 37846943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease.
    Flora A; Kozera E; Frew JW
    Exp Dermatol; 2022 Apr; 31(4):498-515. PubMed ID: 35114021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.
    Wu BC; Patel ED; Ortega-Loayza AG
    Br J Dermatol; 2017 Jul; 177(1):72-83. PubMed ID: 27864925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in managing and understanding pyoderma gangrenosum.
    Fletcher J; Alhusayen R; Alavi A
    F1000Res; 2019; 8():. PubMed ID: 31885859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of pyoderma gangrenosum (PG): an updated review.
    Braswell SF; Kostopoulos TC; Ortega-Loayza AG
    J Am Acad Dermatol; 2015 Oct; 73(4):691-8. PubMed ID: 26253362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
    Marzano AV; Damiani G; Ceccherini I; Berti E; Gattorno M; Cugno M
    Br J Dermatol; 2017 Jun; 176(6):1588-1598. PubMed ID: 27943240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrative Review: Pyoderma Gangrenosum.
    Park AN; Raj A; Bajda J; Gorantla VR
    Cureus; 2024 Jan; 16(1):e51805. PubMed ID: 38187026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease.
    Moura RR; Brandão L; Moltrasio C; Agrelli A; Tricarico PM; Maronese CA; Crovella S; Marzano AV
    Sci Rep; 2023 Mar; 13(1):4919. PubMed ID: 36966241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Review of Neutrophilic Diseases.
    Marzano AV; Borghi A; Wallach D; Cugno M
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):114-130. PubMed ID: 28688013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
    Satoh TK
    J Dermatol; 2024 Feb; 51(2):160-171. PubMed ID: 38031879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
    Sawka E; Zhou A; Latour E; Friedman M; Ortega-Loayza AG
    Clin Rheumatol; 2021 Oct; 40(10):3963-3969. PubMed ID: 34002351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial Granulomatous Pyoderma Gangrenosum Involving the Face: A Case Series of Five Patients and a Review of the Literature [Formula: see text].
    Shavit E; Cecchini M; Limacher JJ; Walsh S; Wentworth A; Davis MDP; Alavi A
    J Cutan Med Surg; 2021; 25(4):371-376. PubMed ID: 33541119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.
    Maronese CA; Pimentel MA; Li MM; Genovese G; Ortega-Loayza AG; Marzano AV
    Am J Clin Dermatol; 2022 Sep; 23(5):615-634. PubMed ID: 35606650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyoderma gangrenosum: a review of pathogenesis and treatment.
    Ahn C; Negus D; Huang W
    Expert Rev Clin Immunol; 2018 Mar; 14(3):225-233. PubMed ID: 29406827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research advances on the pathogenesis and diagnosis of pyoderma gangrenosum].
    Yang L; Yang QW; Fu YJ
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Jun; 38(6):569-573. PubMed ID: 35764584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial ulcerative pyoderma gangrenosum: a report of 2 kindred.
    Alberts JH; Sams HH; Miller JL; King LE
    Cutis; 2002 Jun; 69(6):427-30. PubMed ID: 12078842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of classic ulcerative pyoderma gangrenosum.
    Afifi L; Ortega-Loayza AG; Shinkai K
    Cutis; 2020 Sep; 106(3):119-123;E2;E3. PubMed ID: 33104120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of pyoderma gangrenosum and implications for treatment: a systematic review.
    DeFilippis EM; Feldman SR; Huang WW
    Br J Dermatol; 2015 Jun; 172(6):1487-1497. PubMed ID: 25350484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.